ENO2 and cardiac arrest: In cardiopulmonary arrest and AHT, delayed increases in the neuronal death marker NSE suggested its (or other neuronal death markers) potential utility for prognostic and theragnostic applications, and for the need to evaluate therapies targeting delayed neuronal death in cardiopulmonary arrest and AHT.